When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done.The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the st ...

Investor Presentation Q2 2024 1 Safe Harbor Statement • During the course of this presentation, management may make forward-looking statements regarding financial performance and future events. • We will attempt to identify these statements by use of words such as expect, believe, anticipate, intend, and other words that denote future events. You should understand that, even though our forward-looking statements are based on assumptions we believe are reasonable when made, they are still subject to uncertai ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission file number: 1-13648 _______________________________________________________________________________________________________________ Ba ...

Balchem Corporation (NASDAQ:BCPC) Q2 2024 Earnings Conference Call July 26, 2024 11:00 AM ET Company Participants Martin Bengtsson - Chief Financial Officer Ted Harris - Chairman, President and CEO Conference Call Participants Kyle May - Sidoti and Company Ram Selvaraju - H.C. Wainwright Operator Greetings. And welcome to the Balchem Second Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator ...

Blachem (BCPC) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.93 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.16%. A quarter ago, it was expected that this chemical company would post earnings of $0.94 per share when it actually produced earnings of $0.89, delivering a surprise of -5.32%.Over the last four quarters, the company ...

Exhibit 99.1 5 Paragon Drive Montvale, NJ 07645 p.845.326.5600 f. 845.326.5702 Human Nutrition & Health | Animal Nutrition & Health | Specialty Products Balchem Corporation Reports Second Quarter 2024 Financial Results Second Quarter 2024 Financial Highlights: Recent Highlights: Montvale, NJ, July 26, 2024 - Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal second quarter ended June 30, 2024. The Company reported quarterly net sales of $234.1 million, quarterly net earn ...

Core Insights - Balchem Corporation reported solid financial results for the second quarter of 2024, with record earnings from operations and adjusted EBITDA, driven by strong performance in the Human Nutrition and Health and Specialty Products segments [1][2][12] Financial Performance - Quarterly net sales reached $234.1 million, a 1.2% increase compared to the same quarter last year [2][4] - Adjusted EBITDA was a record $62.3 million, reflecting a 5.0% increase year-over-year [2][5] - GAAP net earnings were $32.1 million, up 6.5% from the prior year quarter, with earnings per share increasing to $0.98 from $0.93 [2][5] - Free cash flow for the quarter was $38.4 million, supported by strong cash flows from operations of $45.0 million [2][11] Segment Performance - The Human Nutrition & Health segment generated sales of $147.9 million, a 9.0% increase, with earnings from operations rising 21.3% to $33.4 million [6][12] - The Animal Nutrition & Health segment saw a decline in sales to $49.6 million, a decrease of 19.2%, with earnings from operations dropping 64.9% to $2.7 million [7][12] - The Specialty Products segment reported sales of $35.1 million, a 7.2% increase, with earnings from operations reaching a record $11.2 million, up 20.8% [8][12] Cash Flow and Debt Management - Strong cash flows allowed the company to repay $35.0 million of revolving debt, reducing net debt to $202.8 million, with a leverage ratio of 0.9 times [3][11] - The company maintained a cash balance of $63.7 million as of June 30, 2024 [11][20] Strategic Initiatives - Balchem launched a new product, Optifolin+®, aimed at supporting cellular health, enhancing its portfolio in the minerals and nutrients market [3][12] - The company continues to focus on strategic growth initiatives while delivering solid financial results [3][12]

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Whil ...

Company Overview - Balchem Corporation develops, manufactures, and markets specialty ingredients aimed at improving health and well-being across various industries globally [3] - The company operates through three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products [3] - The Human Nutrition & Health segment focuses on customized food and beverage ingredient systems and key nutrients for food, supplement, and pharmaceutical applications [3] - The Animal Nutrition & Health segment supplies products to various animal health markets [3] - Specialty Products offers specialty-packaged chemicals for healthcare and other industries, as well as chelated minerals for the micronutrient agricultural market [3] Upcoming Events - A conference call is scheduled for July 26, 2024, at 11:00 AM ET to review second quarter results [1] - Second quarter results will be published before the market opens on the same day [1] - The press release and financial exhibits will be available on the company website prior to the conference call [1] Conference Call Details - Participants can join the conference call by calling toll-free 1-877-407-8289 or local dial-in 1-201-689-8341, five minutes before the start time [2] - A replay of the conference call will be available three hours after its conclusion until the end of the day on August 9, 2024 [2] - To access the replay, dial 1-877-660-6853 or local dial-in 1-201-612-7415, using conference ID 13747779 [2]

MONTVALE, N.J., July 12, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today announced that a conference call will be held on Friday, July 26, 2024, at 11:00 AM Eastern Time (ET) to review second quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. Second quarter results will be published prior to the market opening on Friday, July 26, 2024. The press release, and its accompanying financial exhibits, will also be available on the ...